Atopic dermatitis
Conditions
Interventions
Applying ATP087 cream and ra76 cream twice a day for 1 weeks ->
Applying ra76 cream twice a day for 6 weeks (In case of disease progression, it is allowed to apply ATP087 cream in combination) ->
Post-observation period for 4week
Sponsors
Exam CO.,LTD
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with atopic dermatitis. 2) Patients with mild or moderate rash on test site (both arms). 3) Patients who use moisturizer on body including both arms to control atopic dermatitis.
Exclusion criteria
Exclusion criteria: 1) Patients with severe skin disorders on test site (both arms) and deemed inappropriate to participate in this study by the principal investigator or sub-investigators. 2) Patients with any complications which affect the results of this study. 3) Patients who might use any external use medicines, anti-allergy drugs, or immunosuppressants. 4) Patients with a past history of allergy with test drug components. 5) Patients with hemorrhagic disease. 6) Patients with risk of serious disease in an injury. 7) Patients with menopausal trouble or on menopausal hormone therapy 8) Pregnant or lactating patients. Patients with suspicion of pregnancy. 9) Patients deemed inappropriate to participate in this study by the principal investigator or sub-investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transition of severity classification (simple method) of atopic dermatitis developed by the advisory committee of atopic dermatitis severity classification of Japanese Dermatological Association at test site (both arms). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Transepidermal water loss, water content of the stratum corneum, erythema and pigmentation, and skin surface topography at test site (both arms), etc. 2) Questionnaires for QOL assessment in atopic dermatitis. | — |
Countries
Japan
Contacts
Public ContactYukiyoshi Katsumata
Exam CO.,LTD DermaLabo
Outcome results
None listed